71. Idiopathic osteonecrosis of the femoral head Clinical trials / Disease details


Clinical trials : 2 Drugs : 3 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 7

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000032412
2016/08/2127/04/2018Multicenter clinical trial: treatment effect of lansoprazole on non-traumatic osteonecrosis of the femoral headMulticenter clinical trial: treatment effect of lansoprazole on non-traumatic osteonecrosis of the femoral head - Clinical trial for treatment effect of non-traumatic osteonecrosis of the femoral head idiopathic osteonecrosis of the femoral headLansoprazole 30mg orally once a day for one year
No administration
Sapporo Medical University HospitalNULLComplete: follow-up complete18years-old75years-oldMale and Female100Phase 2Japan
2JPRN-UMIN000009610
2012/12/2626/12/2012Clinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatmentClinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatment - Risk reduction of progress of ION idiopathic osteonecrosis of the femoral headTeriparatide Acetate
Normal treatment
Asahikawa Medical UniversityNULLComplete: follow-up complete20years-oldNot applicableMale and Female50Not selectedJapan